Cadre Holdings, Inc. CDRE
33.08 USD -1.00 (-2.93%)
At closeNov 13, 2026, 4:56 AM EST
32.93 -0.15 -0.45%
Pre-market · Nov 13, 4:56 AM ET
33.08 Day range 34.60
24.07 52-week range 48.76
- YTD
- -19.00%
- 1 year
- -23.48%
News
marketbeat.com What Cadre (CDRE) Said on Its Q3 Earnings Call Cadre NYSE: CDRE raised its full-year 2026 outlook for the second consecutive quarter after third-quarter sales rose 30%, helped by acquisitions and an explosives-disposal project that moved into the…
seekingalpha.com Cadre Holdings: The Business Is Strong, But The Stock Has Rallied (Rating Downgrade) Cadre Holdings delivered strong Q3 results, with accelerating organic growth and improved margins while beating estimates. I have a small discomfort with capital allocation: buybacks, M&A, dividends,…
benzinga.com Cadre Hldgs Q3 2026 Earnings Call Transcript Cadre Hldgs (NYSE:CDRE) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you…
benzinga.com CORRECTION: Cadre Hldgs Q3 EPS $0.37 Beats $0.28 Estimate, Sales $202.876M Beat $190.647M Estimate Cadre Hldgs (NYSE:CDRE) reported quarterly earnings of $0.37 per share which beat the analyst consensus estimate of $0.28 by 32.14 percent. This is a 37.04 percent increase over earnings of $0.27 per…
benzinga.com Cadre Hldgs Raises FY2026 Sales Guidance from $749.000M-$769.000M to $756.000M-$769.000M vs $759.431M Est Cadre Hldgs (NYSE:CDRE) raises FY2026 sales outlook from $749.000 million-$769.000 million to $756.000 million-$769.000 million vs $759.431 million estimate.
benzinga.com Cadre Hldgs Q3 EPS $0.27 Misses $0.28 Estimate, Sales $202.876M Beat $190.647M Estimate Cadre Hldgs (NYSE:CDRE) reported quarterly earnings of $0.27 per share which missed the analyst consensus estimate of $0.28 by 3.57 percent. This is unchanged from the same period last year. The…
benzinga.com JP Morgan Maintains Overweight on Cadre Hldgs, Lowers Price Target to $35 JP Morgan analyst Tomohiko Sano maintains Cadre Hldgs (NYSE:CDRE) with a Overweight and lowers the price target from $45 to $35.